Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 32.24% is in line with its 5-year average of 35.53%, around the middle of its 5-year range (28.05%–38.35%).
1.41% below its 12-month average of 32.70%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
32.24%
GROSS MARGIN AVG TTM
32.70%
GROSS MARGIN AVG 3Y
33.55%
GROSS MARGIN AVG 5Y
35.53%
GROSS MARGIN AVG 10Y
36.35%
GROSS MARGIN AVG 15Y
36.32%
GROSS MARGIN AVG 20Y
36.47%
CURRENT VS TTM AVG
-1.41%
CURRENT VS 3Y AVG
-3.89%
CURRENT VS 5Y AVG
-9.26%
CURRENT VS 10Y AVG
-11.32%
CURRENT VS 15Y AVG
-11.23%
CURRENT VS 20Y AVG
-11.60%
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-45.35%
vs the sector median at left
Charles River Laboratories International, Inc.
Market Cap
$13.52B
Gross Margin
32.24%
TTM Avg
32.70%
3Y Avg
33.55%
5Y Avg
35.53%
Market Cap
$13.20B
Gross Margin
64.37%
TTM Avg
63.66%
3Y Avg
64.40%
5Y Avg
64.61%
Market Cap
$12.85B
Gross Margin
30.08%
TTM Avg
33.76%
3Y Avg
35.72%
5Y Avg
36.84%
Market Cap
$11.95B
Gross Margin
95.71%
TTM Avg
68.63%
3Y Avg
54.72%
5Y Avg
59.42%
Market Cap
$15.60B
Gross Margin
54.69%
TTM Avg
54.56%
3Y Avg
56.03%
5Y Avg
57.27%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | $13.52B | 32.24% | 32.70% | 33.55% | 35.53% |
| The Cooper Companies, Inc. (COO)vs › | $13.20B | 64.37% | 63.66% | 64.40% | 64.61% |
| Revvity, Inc. (RVTY)vs › | $14.18B | 52.11% | 50.55% | 50.58% | 52.43% |
| Baxter International Inc. (BAX)vs › | $12.85B | 30.08% | 33.76% | 35.72% | 36.84% |
| Penumbra, Inc. (PEN)vs › | $12.58B | 67.84% | 65.17% | 64.50% | 63.66% |
| Exelixis, Inc. (EXEL)vs › | $14.50B | 96.48% | 96.44% | 96.31% | 96.33% |
| Encompass Health Corporation (EHC)vs › | $11.95B | 95.71% | 68.63% | 54.72% | 59.42% |
| DaVita Inc. (DVA)vs › | $11.56B | 31.02% | 29.95% | 30.17% | 30.48% |
| Solventum Corporation (SOLV)vs › | $15.60B | 54.69% | 54.56% | 56.03% | 57.27% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 65.77% | 65.28% | 66.17% | 66.85% |
Gross Margin
32.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-27 | 36.19% |
| 2026-03-28 | 28.05% |
| 2025-12-27 | 30.96% |
| 2025-09-27 | 33.72% |
| 2025-06-28 | 34.59% |
| 2025-03-29 | 32.28% |
| 2024-12-31 | 28.35% |
| 2024-09-28 | 34.56% |
| 2024-06-29 | 34.47% |
| 2024-03-30 | 34.09% |
| 2023-12-31 | 35.92% |
| 2023-09-30 | 35.25% |
| 2023-07-01 | 37.64% |
| 2023-04-01 | 36.69% |
| 2022-12-31 | 36.27% |
| 2022-09-24 | 37.43% |
| 2022-06-25 | 36.66% |
| 2022-03-26 | 36.85% |
| 2021-12-31 | 38.35% |
| 2021-09-25 | 37.64% |
| 2021-06-26 | 37.40% |
| 2021-03-27 | 37.39% |
| 2020-12-31 | 37.92% |
| 2020-09-26 | 38.92% |
| 2020-06-27 | 34.02% |
| 2020-03-28 | 35.65% |
| 2019-12-31 | 37.95% |
| 2019-09-28 | 36.85% |
| 2019-06-29 | 36.21% |
| 2019-03-30 | 35.03% |
| 2018-12-31 | 37.64% |
| 2018-09-29 | 36.94% |
| 2018-06-30 | 36.90% |
| 2018-03-31 | 36.74% |
| 2017-12-31 | 35.06% |
| 2017-09-30 | 38.09% |
| 2017-07-01 | 39.50% |
| 2017-04-01 | 38.44% |
| 2016-12-31 | 38.54% |
| 2016-09-24 | 36.71% |
| 2016-06-25 | 39.11% |
| 2016-03-26 | 39.67% |
| 2015-12-31 | 39.73% |
| 2015-09-26 | 39.51% |
| 2015-06-27 | 39.10% |
| 2015-03-28 | 37.35% |
| 2014-12-31 | 36.40% |
| 2014-09-27 | 36.10% |
| 2014-06-28 | 36.82% |
| 2014-03-29 | 36.35% |
| 2013-12-31 | 31.95% |
| 2013-09-28 | 34.21% |
| 2013-06-29 | 35.01% |
| 2013-03-30 | 35.78% |
| 2012-12-31 | 33.76% |
| 2012-09-29 | 33.46% |
| 2012-06-30 | 36.38% |
| 2012-03-31 | 36.44% |
| 2011-12-31 | 34.56% |
| 2011-09-24 | 33.40% |
| 2011-06-25 | 36.88% |
| 2011-03-26 | 35.91% |
| 2010-12-31 | 34.95% |
| 2010-09-25 | 32.78% |
| 2010-06-26 | 34.50% |
| 2010-03-27 | 33.36% |
| 2009-12-31 | 33.90% |
| 2009-09-26 | 35.82% |
| 2009-06-27 | 37.14% |
| 2009-03-28 | 35.89% |
| 2008-12-31 | 35.99% |
| 2008-09-27 | 38.07% |
| 2008-06-28 | 39.19% |
| 2008-03-29 | 38.61% |
| 2007-12-31 | 37.03% |
| 2007-09-29 | 39.46% |
| 2007-06-30 | 39.34% |
| 2007-03-31 | 39.69% |
| 2006-12-31 | 37.44% |
| 2006-09-30 | 38.64% |
| 2006-07-01 | 39.99% |
| 2006-04-01 | 33.66% |
| 2005-12-31 | 36.25% |
| 2005-09-24 | 38.98% |
| 2005-06-25 | 35.85% |
| 2005-03-26 | 38.22% |
| 2004-12-31 | 36.01% |
| 2004-09-25 | 39.42% |
| 2004-06-26 | 41.41% |
| 2004-03-27 | 39.87% |
| 2003-12-31 | 38.20% |
| 2003-09-27 | 37.36% |
| 2003-06-28 | 38.60% |
| 2003-03-29 | 38.11% |
| 2002-12-31 | 37.18% |
| 2002-09-28 | 37.83% |
